tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ADC Therapeutics sees Q3 sales of zynlonta about $15.8M
PremiumThe FlyADC Therapeutics sees Q3 sales of zynlonta about $15.8M
27d ago
ADC Therapeutics announces $60M private placement
Premium
The Fly
ADC Therapeutics announces $60M private placement
27d ago
Positive Buy Rating for ADC Therapeutics Amid Promising Clinical Trials and Strong Valuation
Premium
Ratings
Positive Buy Rating for ADC Therapeutics Amid Promising Clinical Trials and Strong Valuation
1M ago
ADC Therapeutics’ LOTIS-10 Study: A Potential Game-Changer in Lymphoma Treatment
PremiumCompany AnnouncementsADC Therapeutics’ LOTIS-10 Study: A Potential Game-Changer in Lymphoma Treatment
4M ago
ADC Therapeutics files to sell 27.73M common shares for holders
Premium
The Fly
ADC Therapeutics files to sell 27.73M common shares for holders
4M ago
ADC Therapeutics price target lowered to $5 from $8 at RBC Capital
Premium
The Fly
ADC Therapeutics price target lowered to $5 from $8 at RBC Capital
5M ago
ADC Therapeutics to sell 13M shares at $3.53 in private placement
PremiumThe FlyADC Therapeutics to sell 13M shares at $3.53 in private placement
5M ago
ADC Therapeutics announces updated data from LOTIS-7 trial
Premium
The Fly
ADC Therapeutics announces updated data from LOTIS-7 trial
5M ago
ADC Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
ADC Therapeutics Approves Key Proposals at Annual Meeting
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100